TMCnet News
Mersana Therapeutics to Present at the 2019 Cantor Global Healthcare ConferenceCAMBRIDGE, Mass., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ:MRSN) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that Anna Protopapas, President and Chief Executive Officer, will present a company overview at the 2019 Cantor Global Healthcare Conference in New York, NY on Friday, October 4, 2019 at 7:45 a.m. ET. A live webcast of the presentation will be available on the Investors & Media section of Mersana’s website at www.mersana.com. Archived replays will be available for approximately 90 days following the presentation. About Mersana Therapeutics Contact: Investor & Media Contact |